| Ms Michelle Denise Martineau, WHCNP | |
|
601 W Garriott Rd, Enid, OK 73701-5524 | |
| (580) 977-1903 | |
| (580) 548-1434 |
| Full Name | Ms Michelle Denise Martineau |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Obstetrics & Gynecology |
| Location | 601 W Garriott Rd, Enid, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609850155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | 100587 (Oklahoma) | Primary |
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
The combination of two commonly used diuretics, each at half dose, can significantly reduce blood pressure without the side-effects caused by full doses of either alone, researchers from the PATHWAY 3 study have found.
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
Colorado-based Traceability Institute announced today the dates of the first executive summit designed to initiate consensus to achieve multi-system interoperability with the goal of accomplishing a more sustainable and safer US food supply chain.
CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Michelle Denise Martineau, WHCNP 5300 N Independence Ave, 280, Oklahoma City, OK 73112-5556 Ph: (580) 977-1903 | Ms Michelle Denise Martineau, WHCNP 601 W Garriott Rd, Enid, OK 73701-5524 Ph: (580) 977-1903 |
News Archive
The combination of two commonly used diuretics, each at half dose, can significantly reduce blood pressure without the side-effects caused by full doses of either alone, researchers from the PATHWAY 3 study have found.
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
Colorado-based Traceability Institute announced today the dates of the first executive summit designed to initiate consensus to achieve multi-system interoperability with the goal of accomplishing a more sustainable and safer US food supply chain.
CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.
› Verified 1 days ago
Morgan Rose Messenger, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 S Van Buren St, Enid, OK 73703 Phone: 580-234-9355 | |
Mr. David A Ward, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 302 N Independence Street, Suite 600, Enid, OK 73701 Phone: 580-242-1300 Fax: 580-237-7913 | |
Mr. Nathan Veral Hollenbeck, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 620 S Madison St Ste 209a, Enid, OK 73701 Phone: 580-233-2300 | |
Mrs. Frances Colleen Billings, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 305 S 5th St, Enid, OK 73701 Phone: 580-233-6100 | |
Lora May Vaverka, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 330 S 5th St Ste 500, Enid, OK 73701 Phone: 580-249-5504 Fax: 580-234-5933 | |
Blaire Blankinship, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3201 N Van Buren St Ste 350, Enid, OK 73703 Phone: 580-366-0844 Fax: 580-297-5197 | |
Ms. Gigi Campbell, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1517 E Walnut Ave, Enid, OK 73701 Phone: 580-402-5329 |